Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 11;25(8):4223.
doi: 10.3390/ijms25084223.

Vasorelaxant and Blood Pressure-Lowering Effects of Cnidium monnieri Fruit Ethanol Extract in Sprague Dawley and Spontaneously Hypertensive Rats

Affiliations

Vasorelaxant and Blood Pressure-Lowering Effects of Cnidium monnieri Fruit Ethanol Extract in Sprague Dawley and Spontaneously Hypertensive Rats

Junkyu Park et al. Int J Mol Sci. .

Abstract

Cnidium monnieri (L.) Cusson, a member of the Apiaceae family, is rich in coumarins, such as imperatorin and osthole. Cnidium monnieri fruit (CM) has a broad range of therapeutic potential that can be used in anti-bacterial, anti-cancer, and sexual dysfunction treatments. However, its efficacy in lowering blood pressure through vasodilation remains unknown. This study aimed to assess the potential therapeutic effect of CM 50% ethanol extract (CME) on hypertension and the mechanism of its vasorelaxant effect. CME (1-30 µg/mL) showed a concentration-dependent vasorelaxation on constricted aortic rings in Sprague Dawley rats induced by phenylephrine via an endothelium-independent mechanism. The vasorelaxant effect of CME was inhibited by blockers of voltage-dependent and Ca2+-activated K+ channels. Additionally, CME inhibited the vascular contraction induced by angiotensin II and CaCl2. The main active compounds of CM, i.e., imperatorin (3-300 µM) and osthole (1-100 µM), showed a concentration-dependent vasorelaxation effect, with half-maximal effective concentration values of 9.14 ± 0.06 and 5.98 ± 0.06 µM, respectively. Orally administered CME significantly reduced the blood pressure of spontaneously hypertensive rats. Our research shows that CME is a promising treatment option for hypertension. However, further studies are required to fully elucidate its therapeutic potential.

Keywords: Cnidium monnieri fruit; hypertension; imperatorin; osthole; vasorelaxation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Qualitative and quantitative HPLC analysis of osthole and imperatorin in the fruit of C. monnieri: (A) 50% ethanol extract (CME); (B) water extract (CMW). The retention times of the peak levels of imperatorin and osthole were 4.37 min and 5.25 min, respectively.
Figure 2
Figure 2
Vasorelaxant effects of C. monnieri 50% ethanol extract (CME) and water extract (CMW) on contractile responses induced by phenylephrine (PE): (A,C) Cumulative concentration–response curves and (B,D) representative traces of CME and CMW on endothelium-intact rat aortic rings pre-constricted with PE (1 μM). Unpaired t-test employed for statistical comparisons. Values are expressed as mean ± SEM (n = 4). ** p < 0.01 vs. control, *** p < 0.001 vs. control.
Figure 3
Figure 3
Vasorelaxant effects of C. monnieri 50% ethanol extract (CME) in endothelium-intact or endothelium-denuded rat aortic rings: (A) Cumulative concentration–response curves and (B) representative traces of CME on endothelium-intact [Endo (+)] or endothelium-denuded [Endo (−)] rat aortic rings pre-constricted with phenylephrine (PE, 1 μM). An unpaired t-test was employed for statistical comparisons. Values are expressed as mean ± SEM (n = 4). * p < 0.05, *** p < 0.001 vs. Endo(+) control. ## p < 0.01, ### p < 0.001 vs. Endo(−) control.
Figure 4
Figure 4
Effect of K+ channel blockers on C. monnieri 50% ethanol extract (CME)-induced vasorelaxation: (A) Cumulative concentration–response curves and (B) representative traces of rat aortic rings. K+ channel blockers included 4-aminopyridine (4-AP), tetraethylammonium (TEA), glibenclamide (Glib), and barium chloride (BaCl2), and the aortic rings were pre-constricted with phenylephrine (PE, 1 μM). Statistical comparisons were conducted using an unpaired t-test. Values are presented as mean ± SEM (n = 5). * p < 0.05, *** p < 0.001 vs. CME.
Figure 5
Figure 5
Effect of C. monnieri 50% ethanol extract (CME) on extracellular Ca2+-induced contraction pre-treated with phenylephrine (PE) and KCl. Inhibitory effect of CME (30 and 300 µg/mL) induced by extracellular CaCl2 (0.3–10 mM) constriction on aortic rings pre-treated with: (A) PE (1 μM), (C) KCl (60 mM), and (B,D) representative traces. Statistical comparisons were conducted using an unpaired t-test. Values are expressed as mean ± SEM (n = 4). * p < 0.05, *** p < 0.001 vs. control.
Figure 6
Figure 6
Effect of C. monnieri 50% ethanol extract (CME) and SK&F96365 on phenylephrine (PE)-induced contraction in the presence of nifedipine: (A) The effects and (B) traces of CME (30 µg/mL) on PE-induced contraction in the presence of nifedipine (10 µM). Statistical comparisons were conducted using an unpaired t-test. Values are expressed as mean ± SEM (n = 4). * p < 0.05, *** p < 0.001.
Figure 7
Figure 7
Inhibitory effects of C. monnieri 50% ethanol extract (CME) pre-treatment on angiotenin II (Ang II)-induced contraction. (A) Inhibitory effect and (B) representative original traces of CME (300 µg/mL) are shown in the contraction induced by Ang II (10−9–10−7 M) on the endothelium-intact aortic rings. Statistical comparisons were conducted using an unpaired t-test. Values are expressed as the mean ± SEM (n = 4). ** p < 0.01, *** p < 0.001 vs. control.
Figure 8
Figure 8
Vasorelaxant effect of the main active components in C. monnieri 50% ethanol extract (CME): (A,C) Cumulative concentration–response curves and (B,D) representative traces of imperatorin and osthole on endothelium-intact rat aortic rings pre-constricted with phenylephrine (PE, 1 μM). Statistical comparisons were conducted using an unpaired t-test. Values are expressed as mean ± SEM (n = 4). * p < 0.05, *** p < 0.001 vs. control.
Figure 9
Figure 9
Hypotensive effect of C. monnieri 50% ethanol extract (CME) in spontaneously hypertensive rats. Systolic blood pressure (A) and diastolic blood pressure (B) were measured at the baseline and 1, 2, 4, 8, and 12 h after CME (100, 300, and 1000 mg/kg, p.o.) administration. Amlodipine (1 mg/kg, i.p.) was used as a positive control. Vehicle group treated with dimethyl sulfoxide (DMSO, i.p.) in the same capacity as a solvent. Values are expressed as the mean ± SEM (n = 4). Two-way ANOVA and an unpaired t-test were used for statistical comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control. ## p < 0.01, ### p < 0.001 vs. vehicle (DMSO).
Figure 10
Figure 10
The morphology of Cnidium monnieri (L.) Cusson used in the experiment: (A) the fruit; (B) the whole plant. The photographs were taken before the experiment.

Similar articles

Cited by

References

    1. Zhou B., Carrillo-Larco R.M., Danaei G., Riley L.M., Paciorek C.J., Stevens G.A., Gregg E.W., Bennett J.E., Solomon B., Singleton R.K., et al. (NCD-RisC), NCD Risk Factor Collaboration. Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control from 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies with 104 million Participants. Lancet. 2021;398:957–980. doi: 10.1016/S0140-6736(21)01330-1. - DOI - PMC - PubMed
    1. Zhou B., Perel P., Mensah G.A., Ezzati M. Global Epidemiology, Health Burden and Effective Interventions for Elevated Blood Pressure and Hypertension. Nat. Rev. Cardiol. 2021;18:785–802. doi: 10.1038/s41569-021-00559-8. - DOI - PMC - PubMed
    1. Przezak A., Bielka W., Pawlik A. Hypertension and Type 2 Diabetes—The Novel Treatment Possibilities. Int. J. Mol. Sci. 2022;23:6500. doi: 10.3390/ijms23126500. - DOI - PMC - PubMed
    1. Bhatt S.P., Luqman-Arafath T.K., Guleria R. Non-Pharmacological Management of Hypertension. Indian J. Med. Sci. 2007;61:616–624. - PubMed
    1. Doroszko A., Janus A., Szahidewicz-Krupska E., Mazur G., Derkacz A. Resistant Hypertension. Adv. Clin. Exp. Med. 2016;25:173–183. doi: 10.17219/acem/58998. - DOI - PubMed